Copyright Reports & Markets. All rights reserved.

Global GMP Tumor Necrosis Factor Alpha Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of GMP Tumor Necrosis Factor Alpha
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of GMP Tumor Necrosis Factor Alpha by Type
    • 1.3.1 Overview: Global GMP Tumor Necrosis Factor Alpha Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global GMP Tumor Necrosis Factor Alpha Consumption Value Market Share by Type in 2023
    • 1.3.3 25μg
    • 1.3.4 50μg
    • 1.3.5 Others
  • 1.4 Global GMP Tumor Necrosis Factor Alpha Market by Application
    • 1.4.1 Overview: Global GMP Tumor Necrosis Factor Alpha Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Cell/Gene Therapy
    • 1.4.3 Tissue-Engineered Products
    • 1.4.4 Others
  • 1.5 Global GMP Tumor Necrosis Factor Alpha Market Size & Forecast
  • 1.6 Global GMP Tumor Necrosis Factor Alpha Market Size and Forecast by Region
    • 1.6.1 Global GMP Tumor Necrosis Factor Alpha Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global GMP Tumor Necrosis Factor Alpha Market Size by Region, (2019-2030)
    • 1.6.3 North America GMP Tumor Necrosis Factor Alpha Market Size and Prospect (2019-2030)
    • 1.6.4 Europe GMP Tumor Necrosis Factor Alpha Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size and Prospect (2019-2030)
    • 1.6.6 South America GMP Tumor Necrosis Factor Alpha Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa GMP Tumor Necrosis Factor Alpha Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Miltenyi Biotec
    • 2.1.1 Miltenyi Biotec Details
    • 2.1.2 Miltenyi Biotec Major Business
    • 2.1.3 Miltenyi Biotec GMP Tumor Necrosis Factor Alpha Product and Solutions
    • 2.1.4 Miltenyi Biotec GMP Tumor Necrosis Factor Alpha Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Miltenyi Biotec Recent Developments and Future Plans
  • 2.2 Bio-Techne
    • 2.2.1 Bio-Techne Details
    • 2.2.2 Bio-Techne Major Business
    • 2.2.3 Bio-Techne GMP Tumor Necrosis Factor Alpha Product and Solutions
    • 2.2.4 Bio-Techne GMP Tumor Necrosis Factor Alpha Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bio-Techne Recent Developments and Future Plans
  • 2.3 GE Healthcare
    • 2.3.1 GE Healthcare Details
    • 2.3.2 GE Healthcare Major Business
    • 2.3.3 GE Healthcare GMP Tumor Necrosis Factor Alpha Product and Solutions
    • 2.3.4 GE Healthcare GMP Tumor Necrosis Factor Alpha Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 GE Healthcare Recent Developments and Future Plans
  • 2.4 Lonza
    • 2.4.1 Lonza Details
    • 2.4.2 Lonza Major Business
    • 2.4.3 Lonza GMP Tumor Necrosis Factor Alpha Product and Solutions
    • 2.4.4 Lonza GMP Tumor Necrosis Factor Alpha Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Lonza Recent Developments and Future Plans
  • 2.5 CellGenix
    • 2.5.1 CellGenix Details
    • 2.5.2 CellGenix Major Business
    • 2.5.3 CellGenix GMP Tumor Necrosis Factor Alpha Product and Solutions
    • 2.5.4 CellGenix GMP Tumor Necrosis Factor Alpha Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 CellGenix Recent Developments and Future Plans
  • 2.6 ReproCELL
    • 2.6.1 ReproCELL Details
    • 2.6.2 ReproCELL Major Business
    • 2.6.3 ReproCELL GMP Tumor Necrosis Factor Alpha Product and Solutions
    • 2.6.4 ReproCELL GMP Tumor Necrosis Factor Alpha Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 ReproCELL Recent Developments and Future Plans
  • 2.7 PeproTech
    • 2.7.1 PeproTech Details
    • 2.7.2 PeproTech Major Business
    • 2.7.3 PeproTech GMP Tumor Necrosis Factor Alpha Product and Solutions
    • 2.7.4 PeproTech GMP Tumor Necrosis Factor Alpha Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 PeproTech Recent Developments and Future Plans
  • 2.8 Sino Biological
    • 2.8.1 Sino Biological Details
    • 2.8.2 Sino Biological Major Business
    • 2.8.3 Sino Biological GMP Tumor Necrosis Factor Alpha Product and Solutions
    • 2.8.4 Sino Biological GMP Tumor Necrosis Factor Alpha Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Sino Biological Recent Developments and Future Plans
  • 2.9 Creative Bioarray
    • 2.9.1 Creative Bioarray Details
    • 2.9.2 Creative Bioarray Major Business
    • 2.9.3 Creative Bioarray GMP Tumor Necrosis Factor Alpha Product and Solutions
    • 2.9.4 Creative Bioarray GMP Tumor Necrosis Factor Alpha Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Creative Bioarray Recent Developments and Future Plans
  • 2.10 Akron Biotech
    • 2.10.1 Akron Biotech Details
    • 2.10.2 Akron Biotech Major Business
    • 2.10.3 Akron Biotech GMP Tumor Necrosis Factor Alpha Product and Solutions
    • 2.10.4 Akron Biotech GMP Tumor Necrosis Factor Alpha Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Akron Biotech Recent Developments and Future Plans
  • 2.11 Almog
    • 2.11.1 Almog Details
    • 2.11.2 Almog Major Business
    • 2.11.3 Almog GMP Tumor Necrosis Factor Alpha Product and Solutions
    • 2.11.4 Almog GMP Tumor Necrosis Factor Alpha Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Almog Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global GMP Tumor Necrosis Factor Alpha Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of GMP Tumor Necrosis Factor Alpha by Company Revenue
    • 3.2.2 Top 3 GMP Tumor Necrosis Factor Alpha Players Market Share in 2023
    • 3.2.3 Top 6 GMP Tumor Necrosis Factor Alpha Players Market Share in 2023
  • 3.3 GMP Tumor Necrosis Factor Alpha Market: Overall Company Footprint Analysis
    • 3.3.1 GMP Tumor Necrosis Factor Alpha Market: Region Footprint
    • 3.3.2 GMP Tumor Necrosis Factor Alpha Market: Company Product Type Footprint
    • 3.3.3 GMP Tumor Necrosis Factor Alpha Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global GMP Tumor Necrosis Factor Alpha Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global GMP Tumor Necrosis Factor Alpha Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global GMP Tumor Necrosis Factor Alpha Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global GMP Tumor Necrosis Factor Alpha Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America GMP Tumor Necrosis Factor Alpha Consumption Value by Type (2019-2030)
  • 6.2 North America GMP Tumor Necrosis Factor Alpha Consumption Value by Application (2019-2030)
  • 6.3 North America GMP Tumor Necrosis Factor Alpha Market Size by Country
    • 6.3.1 North America GMP Tumor Necrosis Factor Alpha Consumption Value by Country (2019-2030)
    • 6.3.2 United States GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 6.3.3 Canada GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe GMP Tumor Necrosis Factor Alpha Consumption Value by Type (2019-2030)
  • 7.2 Europe GMP Tumor Necrosis Factor Alpha Consumption Value by Application (2019-2030)
  • 7.3 Europe GMP Tumor Necrosis Factor Alpha Market Size by Country
    • 7.3.1 Europe GMP Tumor Necrosis Factor Alpha Consumption Value by Country (2019-2030)
    • 7.3.2 Germany GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 7.3.3 France GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 7.3.5 Russia GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 7.3.6 Italy GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific GMP Tumor Necrosis Factor Alpha Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific GMP Tumor Necrosis Factor Alpha Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Region
    • 8.3.1 Asia-Pacific GMP Tumor Necrosis Factor Alpha Consumption Value by Region (2019-2030)
    • 8.3.2 China GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 8.3.3 Japan GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 8.3.5 India GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 8.3.7 Australia GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America GMP Tumor Necrosis Factor Alpha Consumption Value by Type (2019-2030)
  • 9.2 South America GMP Tumor Necrosis Factor Alpha Consumption Value by Application (2019-2030)
  • 9.3 South America GMP Tumor Necrosis Factor Alpha Market Size by Country
    • 9.3.1 South America GMP Tumor Necrosis Factor Alpha Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa GMP Tumor Necrosis Factor Alpha Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa GMP Tumor Necrosis Factor Alpha Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Country
    • 10.3.1 Middle East & Africa GMP Tumor Necrosis Factor Alpha Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)
    • 10.3.4 UAE GMP Tumor Necrosis Factor Alpha Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 GMP Tumor Necrosis Factor Alpha Market Drivers
  • 11.2 GMP Tumor Necrosis Factor Alpha Market Restraints
  • 11.3 GMP Tumor Necrosis Factor Alpha Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 GMP Tumor Necrosis Factor Alpha Industry Chain
  • 12.2 GMP Tumor Necrosis Factor Alpha Upstream Analysis
  • 12.3 GMP Tumor Necrosis Factor Alpha Midstream Analysis
  • 12.4 GMP Tumor Necrosis Factor Alpha Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global GMP Tumor Necrosis Factor Alpha market size was valued at USD 30 million in 2023 and is forecast to a readjusted size of USD 52 million by 2030 with a CAGR of 8.4% during review period.
    Tumor necrosis factor alpha (TNF-α) is a cytokine that plays a central role in inflammation, immune system development, apoptosis, and lipid metabolism. It is mainly produced by monocytes and macrophages as a response to infection, injury, or tumor burden. TNF-α can also be produced from a range of other cell types such as T cells, natural killer cells (NK cells) and neutrophils.
    A significant driver in the GMP Tumor Necrosis Factor Alpha (TNF-α) market is the increasing use of TNF-α as a therapeutic target in various inflammatory and autoimmune diseases. TNF-α plays a pivotal role in regulating inflammation, and drugs targeting this molecule have shown efficacy in conditions like rheumatoid arthritis and inflammatory bowel diseases. However, a notable challenge in this market is the need for stringent quality control and compliance with Good Manufacturing Practices (GMP). Ensuring that TNF-α production processes meet the highest standards of quality, safety, and purity while adhering to regulatory requirements poses a significant challenge. Manufacturers must invest in robust GMP-compliant manufacturing processes, quality assurance, and regulatory compliance to deliver safe and effective TNF-α-based therapeutics, meeting the increasing demand for innovative treatments in the field of immunology and inflammation.
    The Global Info Research report includes an overview of the development of the GMP Tumor Necrosis Factor Alpha industry chain, the market status of Cell/Gene Therapy (25μg, 50μg), Tissue-Engineered Products (25μg, 50μg), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of GMP Tumor Necrosis Factor Alpha.
    Regionally, the report analyzes the GMP Tumor Necrosis Factor Alpha markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global GMP Tumor Necrosis Factor Alpha market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the GMP Tumor Necrosis Factor Alpha market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the GMP Tumor Necrosis Factor Alpha industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., 25μg, 50μg).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the GMP Tumor Necrosis Factor Alpha market.
    Regional Analysis: The report involves examining the GMP Tumor Necrosis Factor Alpha market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the GMP Tumor Necrosis Factor Alpha market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to GMP Tumor Necrosis Factor Alpha:
    Company Analysis: Report covers individual GMP Tumor Necrosis Factor Alpha players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards GMP Tumor Necrosis Factor Alpha This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cell/Gene Therapy, Tissue-Engineered Products).
    Technology Analysis: Report covers specific technologies relevant to GMP Tumor Necrosis Factor Alpha. It assesses the current state, advancements, and potential future developments in GMP Tumor Necrosis Factor Alpha areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the GMP Tumor Necrosis Factor Alpha market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    GMP Tumor Necrosis Factor Alpha market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    25μg
    50μg
    Others
    Market segment by Application
    Cell/Gene Therapy
    Tissue-Engineered Products
    Others
    Market segment by players, this report covers
    Miltenyi Biotec
    Bio-Techne
    GE Healthcare
    Lonza
    CellGenix
    ReproCELL
    PeproTech
    Sino Biological
    Creative Bioarray
    Akron Biotech
    Almog
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe GMP Tumor Necrosis Factor Alpha product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of GMP Tumor Necrosis Factor Alpha, with revenue, gross margin and global market share of GMP Tumor Necrosis Factor Alpha from 2019 to 2024.
    Chapter 3, the GMP Tumor Necrosis Factor Alpha competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and GMP Tumor Necrosis Factor Alpha market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of GMP Tumor Necrosis Factor Alpha.
    Chapter 13, to describe GMP Tumor Necrosis Factor Alpha research findings and conclusion.

    Buy now